Initially, it examines how GBM cells influence myeloid cells to adopt an immunosuppressive phenotype by secreting cytokines (including CSF-1, IL-10), releasing metabolic byproducts (including lactate and adenosine), and producing extracellular vesicles. Here, IL10 is linked to glioblastoma.